» Articles » PMID: 33365083

Villin is a Biomarker for Reverse Polarity in Colorectal Micropapillary Carcinoma

Overview
Journal Oncol Lett
Specialty Oncology
Date 2020 Dec 28
PMID 33365083
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is a common malignant tumor of digestive system. CRC with micropapillary pattern (MPP) is an aggressive variant of colorectal adenocarcinoma. The aim of the present study was to clarify the clinicopathological significance and the prognostic role of an immunohistochemical marker, MPP, in CRC. The association between MPP and clinicopathological characteristics and prognosis in 286 cases of CRC (286/453 cases had follow-up information) were analysed. Then, 81 tissues without MPP and 90 tissues with MPP were analysed by immunohistochemistry using antibodies against villin, E-cadherin and epithelial membrane antigen (EMA). Bioinformatics was used to evaluate the expression of these three indicators in CRC. The proportion of micropapillary carcinoma in the overall tumour was ≥5%, and was observed in 90/453 cases (19.8%). The present data showed that CRC with MPP displayed higher rates of vascular and lymphatic invasion, a higher metastatic lymph node ratio and a higher pathological tumour and metastasis stage compared with CRC without MPP. The positive expression rates of EMA, E-cadherin and villin were 50.3, 93.4 and 96.5%, respectively. In 90 CRC cases with MPP, EMA inside-out pattern (I/OP) staining was observed in 26 cases (28.9%), and it was often focal and partial, while 37 cases (41.1%) had E-cadherin focal and partial staining compatible with reverse polarity. Villin I/OP staining was observed in 77 cases (85.6%), and circumferential staining predominated over partial staining. Overall, the data suggested that the presence of MPP is significantly associated with aggressive tumour behaviour and worse overall survival rate in CRC. Visualization and distinction of reverse polarity of colorectal micropapillary carcinomas is improved villin compared with EMA or E-cadherin.

Citing Articles

Comprehensive characterization of micropapillary colorectal adenocarcinoma.

Aijala V, Harkonen J, Mantere T, Elomaa H, Sirnio P, Pohjanen V J Pathol. 2025; 265(4):408-421.

PMID: 39917902 PMC: 11880967. DOI: 10.1002/path.6392.


Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma.

He J, Zhang C, Shi Q, Bao F, Pan X, Kuai Y Comput Math Methods Med. 2022; 2022:8367395.

PMID: 35529254 PMC: 9071873. DOI: 10.1155/2022/8367395.

References
1.
Hattori T, Sentani K, Hattori Y, Oue N, Yasui W . Pure invasive micropapillary carcinoma of the esophagogastric junction with lymph nodes and liver metastasis. Pathol Int. 2016; 66(10):583-586. DOI: 10.1111/pin.12450. View

2.
Kitagawa H, Yoshimitsu M, Kaneko M, Ibuki Y, Emi M, Kohashi T . Invasive micropapillary carcinoma component is an independent prognosticator of poorer survival in Stage III colorectal cancer patients. Jpn J Clin Oncol. 2017; 47(12):1129-1134. DOI: 10.1093/jjco/hyx136. View

3.
Yang Y, Liu B, Zhang X, Fu L . Invasive Micropapillary Carcinoma of the Breast: An Update. Arch Pathol Lab Med. 2016; 140(8):799-805. DOI: 10.5858/arpa.2016-0040-RA. View

4.
Wen P, Xu Y, Frankel W, Shen R . Invasive micropapillary carcinoma of the sigmoid colon: distinct morphology and aggressive behavior. Int J Clin Exp Pathol. 2008; 1(5):457-60. PMC: 2480571. View

5.
Fujita T, Konishi M, Gotohda N, Takahashi S, Nakagohri T, Kojima M . Invasive micropapillary carcinoma of the ampulla of Vater with extensive lymph node metastasis: Report of a case. Surg Today. 2010; 40(12):1197-200. DOI: 10.1007/s00595-010-4330-0. View